GlassScriptPhysician profile
Jennifer L Relph
NPI 1558609438
$2,221.66
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $480 · 2023: $974 · 2024: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $773.74 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $381.23 | 2022-2024 | Farxiga, Airsupra, Breztri |
| Abbott Laboratories | $182.51 | 2023 | Freestyle Libre 2 |
| Abbvie INC. | $159.43 | 2023-2024 | |
| Glaxosmithkline, LLC. | $151.85 | 2023-2024 | Arexvy, Shingrix, Bexsero |
| Lilly USA, LLC | $116.63 | 2022-2024 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $105.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.50 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.86 | 2022 | |
| Daiichi Sankyo INC. | $45.43 | 2024 | Injectafer |
| Scilex Pharmaceuticals INC. | $37.74 | 2023-2024 | Ztlido |
| Pfizer INC. | $36.71 | 2023 | |
| Exact Sciences Corporation | $30.93 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $26.08 | 2024 | Krystexxa |
| Idorsia Pharmaceuticals US INC | $14.60 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Relph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.